In May, Michael Fysh attended the New Delhi Division Bench to assist Merck Sharp and Dohme Corporation against Glenmark Pharmaceuticals in a patent infringement action relating to the drug Sitagliptin. The decision was reserved.
+44(0)20 7405 4321
clerks@8newsquare.co.uk